Share

Challenges to the Development of Personalized Medicine

Prof Franҫoise Meunier, EORTC Director General, and Prof Alexander Eggermont, President of the European Academy of Cancer Sciences talk to ecancer.tv about the challenges associated with the development of personalized medicine, including difficulties raising sufficient funds for European cancer trials, the way this can be addressed by collaborations with academia, and the steps that must be taken to overcome the differences in the agendas of academia and industry.

Watch the interview

Back to news list

Related News

  • New European AI assistant to make patient experiences actionable for care and health systems

  • First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer

  • EORTC at ESMO 2026: New findings and ongoing studies

  • EORTC research presented at ESMO 2026

  • EORTC Quality of Life Group at ISOQOL 2026

  • Pink October 2026: Advancing breast cancer research, together

  • EORTC presents new results in neuro-oncology at EANO

  • In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group

  • New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults

  • New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors